There are 350 million people worldwide with rare diseases and about 80% of those diseases, including cystic fibrosis, are caused by faulty genes. In most cases, genetic disorders lack effective treatment options. But that could change in the future thanks to advances in genome editing approaches, including TALEN, CRISPR/Cas9, and the oldest, and most researched approach: zinc-finger nuclease (ZFN).
Your Guide to Investing in Zinc-Finger (ZFN) Gene Editing
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться